Shaping better health
REMEDY : BNSSG referral pathways & Joint Formulary


Home > Formulary : Paediatric > Paediatric Chapters > 7. Obstetrics, gynaecology, and urinary-tract disorders >

BNSSG Paediatric Joint Formulary

7.1 Bladder and urinary disorders

Checked: not set yet by Next Review: not set yet

7.1.1 Urinary frequency, enuresis, and incontinence

First line drugs Second line drugs Specialist drugs Secondary care drugs

 

Antimuscarinics

First line:

Oxybutynin standard-release (TLS Amber Specialist Recommended)

Second line:

Oxybutynin modified-release (TLS Amber Specialist Recommended)

Tolterodine (standard-release & modified-release) (TLS Amber Specialist Recommended)

Third line:

Solifenacin (TLS Amber Specialist Recommended)

Oxybutynin (transdermal) (TLS Red)

 

Beta3-adrenoceptor Agonists

Mirabegron (TLS Amber 3 months)

 

Vassopressin Analogues

Desmopressin (oral tablets/oral lyophilisates) (TLS Green) 

For primary nocturnal enuresis

 

Other

Botulinum toxin type A (TLS Red) 

  • For urinary incontinence/overactive bladder in children where oral antimuscarinic treatments have failed

See Botulinum Toxin A Pathways page for more information

 

7.1.2 Urinary retention

Alpha-adrenoceptor Blockers

Doxazosin (standard-release) (TLS Red)

Tamsulosin capsules (modified-release) (TLS Red)

 

7.1.3 Urological pain

Alkalinising Drugs

Potassium citrate (TLS Green)

Sodium bicarbonate (TLS Green)